A new way to look at drug development
MediVector is a privately held drug development company. It has created a development platform
that dramatically improves the economics of drug development. MediVector has demonstrated in both the
large pharma and biotech settings that its platform reduces development time and cost by as much as 30% over
industry standards. In addition, the probability of success in the late phases of clinical research is
significantly increased.
